Last reviewed · How we verify
NCT07121218
Determination of Physical Fitness Level in Bronchiectasis
trial in Pediatric Patients With Bronchiectasis in 50 participants. Currently enrolling.
1 August 2026
Quick facts
| Lead sponsor | Melis Usul |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 August 2025 |
| Primary completion | 1 August 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 2 locations across Turkey (Türkiye) |
Conditions studied
- Pediatric Patients With Bronchiectasis — all drugs for Pediatric Patients With Bronchiectasis →
Sponsor
Melis Usul
Who can join
Adults 7 to 18, any sex, with Pediatric Patients With Bronchiectasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the physical fitness level of children with bronchiectasis. To determine your physical fitness level, we will conduct some game-like tests. These are completely fun and enjoyable tests (such as running or a sit-to-stand test). Additionally, we will ask you some questions. These questions will help us get to know you better and understand how much you enjoy exercise. To measure your growth level, we will weigh you using a scale. We will also assess your muscle strength using a special device. All these tests will help us understand how much your condition affects you.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07121218
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Melis Usul trials
Trials by the same sponsor.
- NCT07193745 — Respiratory Function, Physical Activity and Fatigue in SLE · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07121218 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Melis Usul
- Last refreshed: 24 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07121218.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing